October 9, 2013
Montréal – Hundreds of researchers from North America, Europe, Australia and Asia have joined together in a consortium to identify the genetic basis of the five most common forms of cancer – breast, prostate, lung, ovarian and colorectal. The group, called the OncoArray Consortium, developed a new customized genotyping tool – the OncoArray – manufactured [...]
October 9, 2013
CARLSBAD, Calif. -- Life Technologies Corporation (NASDAQ: LIFE) today announced that its GlobalFiler™ Express Kit has been approved by the United States Federal Bureau of Investigation for use by laboratories generating DNA profiles for inclusion in the National DNA Index System (NDIS) CODIS Database. NDIS manages the Federal CODIS forensic DNA database, which facilitates the [...]
Shimadzu Instrumentation worth millions fuels transformative year for UT Arlington research
October 9, 2013
The University of Texas at Arlington offers students a new level of experience with the most sophisticated scientific instrumentation this fall with the opening of two new teaching laboratories as part of the Shimadzu Institute for Research Technologies. The newly-opened labs and the Center for Bio-Molecular Imaging, which will open Nov. 15, are part of [...]
Ion World 2013 Showcases Breakthrough Discoveries That Will Shape the Future of Health Care
October 9, 2013
CARLSBAD, Calif. -- Life Technologies Corporation (NASDAQ: LIFE) welcomes scientists and students to attend the 2nd annual Ion World 2013 next-generation sequencing conference, Oct. 20—21, in Boston, MA preceding the American Society of Human Genetics (ASHG) conference. Scientists from around the world will present their latest basic and clinical research and discoveries in areas including [...]
Oxford Nanopore announces £40 million ($64 million) fundraising
October 9, 2013
Oxford Nanopore Technologies Ltd, the UK-based technology company specialising in nanopore-based electronic molecular analysis systems, has raised £40 million in new funding through a private placement of ordinary shares. The investment was received from new and existing investors in the US, UK and mainland Europe. New investors include Odey Asset Management. Funds will be used [...]
Sample6 Secures $11 Million in Series B Financing
October 9, 2013
Boston, Mass. – Sample6, a company focused on applying biotechnology to advance food safety, announced today that it has secured a $11 million Series B financing round led by Canaan Partners. Joining the round are Cultivian Sandbox, a fund which invests in emerging technologies in the food and agriculture industry, and Series A lead investor [...]
October 9, 2013
Cambridge, UK: TAP Biosystems, a leading supplier of innovative cell culture systems and consumables for life science applications, announced that it will introduce its new Cellmate™ Mk9 automated cell culture system at the World Vaccine Congress in Lille, France. The new system is designed for safe, high throughput production of adherent cell-based vaccines in a [...]
October 9, 2013
NETZSCH INSTRUMENTS NORTH AMERICA, LLC (NETZSCH) and PolymerOhio, Inc. (PolymerOhio) are pleased to announce a joint collaboration for thermal analysis and thermal properties contract testing and training services. NETZSCH will provide contract testing services to PolymerOhio members as well as provide training services regarding thermal analysis techniques. The NETZSCH Thermal Analysis Applications Laboratories (Burlington, MA) [...]
Tecan maintains target for profitability and adjusts revenue guidance for 2013
October 9, 2013
Männedorf, Switzerland - The Tecan Group (SIX Swiss Exchange: TECN) today announced that the company continues to grow in a challenging business environment. Tecan maintains its outlook for an increased operating profit margin and adjusts its revenue outlook for 2013. As communicated before, the operating profit margin is expected to grow by around 50 basis [...]
VRL – San Antonio Chooses Intuitive Biosciences
October 9, 2013
MADISON, WI - VRL - San Antonio, a world-leader in research animal diagnostic services, has chosen Intuitive Biosciences' Arrayed Immuno-Multiplexing (AIM) technology to handle its complex commercial needs and enhance its already robust serological services offering. VRL - San Antonio is in the process of enhancing and diversifying their service offering with the addition of [...]
